Robert Glassman, a healthcare pro who advised Pfizer on its purchase of Wyeth last year, has returned to Bank of America Merrill Lynch as a managing director on its healthcare corporate and investment banking team.
Glassman was for the last year a private-equity partner at Orbimed Advisors, the world’s largest healthcare-dedicated investment firm. Bank of America Merrill Lynch announced his return in a press release on Wednesday.
Register or login for access to this item and much more
All Financial Planning content is archived after seven days.
Community members receive:
- All recent and archived articles
- Conference offers and updates
- A full menu of enewsletter options
- Web seminars, white papers, ebooks
Already have an account? Log In
Don't have an account? Register for Free Unlimited Access